Skip to main content
logo
BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.2255
-0.0245 (-9.80%)
At close: Sep 18, 2026

BioCorRx Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.650.80.010.090.210.05
Revenue Growth
107.94%10301.10%-91.40%-58.30%342.99%-60.63%
Gross Profit
0.460.780.010.050.20.04
Operating Income
-5.05-4.83-5.12-3.74-4.7-5.37
Net Income
-3.28-3.44-5.11-3.77-4.37-5.28
Earnings Per Share
-0.14-0.19-0.49-0.45-0.61-0.81
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.020.140.090.070.070.09
Total Debt
2.32.142.811.811.681.65
Net Cash (Debt)
-2.28-2-2.72-1.75-1.61-1.57
Net Cash Growth
------
Net Cash Per Share
-0.09-0.11-0.26-0.21-0.22-0.24

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.36-2.3-1.1-1.85-2.04-3.54
Capital Expenditures
------0
Free Cash Flow
-2.36-2.3-1.1-1.85-2.04-3.54
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
70.52%97.27%78.25%59.64%92.86%87.82%
Operating Margin
-774.96%-606.04%-66829.81%-4194.50%-2196.96%-11121.62%
Pretax Margin
-505.65%-440.11%-67998.72%-4228.90%-2046.77%-10794.33%
Profit Margin
-503.10%-431.51%-66616.10%-4224.89%-2043.30%-10934.66%
FCF Margin
-361.74%-288.28%-14302.07%-2078.60%-954.81%-7332.77%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.558.87649.4475.7534.95600.27